Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationMultiple MyelomaHematopoietic Stem Cell MobilizationMelphalanTransplantation ConditioningTransplantation, HomologousCombined Modality TherapyGranulocyte Colony-Stimulating FactorLeukapheresisAntigens, CD34Hematologic NeoplasmsBlood Component RemovalStem Cell TransplantationAntineoplastic Combined Chemotherapy ProtocolsCyclophosphamideLymphoma, Non-HodgkinTreatment OutcomeMyeloablative AgonistsBusulfanGraft vs Host DiseaseRemission InductionBone Marrow TransplantationGraft SurvivalAntineoplastic Agents, AlkylatingHematopoietic Stem CellsEtoposideRecurrenceThiotepaLymphomaVincristineSalvage TherapyCarmustineCytophagocytosisDisease-Free SurvivalIfosfamideLymphoma, T-CellAmyloidosisBoronic AcidsHodgkin DiseasePyrazinesSurvival RateRetrospective StudiesThalidomideCytarabineStem CellsDexamethasoneHematopoiesisPrednisoneCord Blood Stem Cell TransplantationSurvival AnalysisDoxorubicinTransplantation ChimeraNeoplasmsTissue DonorsTime FactorsWhole-Body IrradiationAntineoplastic AgentsInfectionPOEMS SyndromePlatelet CountHistocompatibilityBone MarrowFollow-Up StudiesHistocompatibility TestingCarboplatinImmunosuppressive AgentsBone Marrow PurgingLeukemia, Myeloid, AcuteTransplantation, IsogeneicVidarabinePlasma CellsLeukemiaBlood Cell CountRecombinant ProteinsImmunophenotypingPrognosisFatal OutcomeProspective StudiesBlood CellsCytomegalovirus InfectionsGraft vs Leukemia EffectFeasibility StudiesMyeloma ProteinsLymphoma, B-CellFlow CytometryMyelodysplastic SyndromesAnemia, AplasticParaproteinemiasBlood Transfusion, AutologousT-LymphocytesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphocyte DepletionLiver TransplantationBone Marrow CellsLeukocytes, MononuclearHematologic DiseasesOpportunistic InfectionsHistiocytosis, Non-Langerhans-Cell